AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Vodak GM 1mg/500mg/0.2mg Tablet SR

Prescription Icon
Prescription Required

Marketer

Abdach Healthcare Pvt. Ltd.

Salt Composition

Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.2mg)

Overview Vodak GM 1mg/500mg/0.2mg Tablet SR

Diabetol-GM 1mg/500mg/0.2mg Extended-Release Tablets are classified as antidiabetic agents. This combination medication treats type 2 diabetes in adults by regulating blood glucose. Diabetol-GM should be ingested with meals, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continued use is crucial, even with controlled glucose levels; abrupt cessation, without medical consultation, risks elevated blood sugar, potentially leading to kidney complications, vision loss, neuropathy, and limb amputation. Remember, this medication complements a comprehensive diabetes management plan encompassing a healthy diet, regular exercise, and weight management as directed by your doctor. Lifestyle modifications are vital for diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect, characterized by sweating, dizziness, headache, and tremors. Learn to recognize and manage these symptoms; maintain regular mealtimes and carry a readily available fast-acting glucose source, such as sweets or juice. Alcohol consumption elevates hypoglycemia risk and should be limited. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, edema, blurred vision, bone fractures, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Individuals with a history of heart disease should inform their physician before commencing treatment. Consult your doctor before use during pregnancy or breastfeeding. Regular blood glucose monitoring is essential, along with potential blood tests to assess blood cell counts and liver function.

Uses of Vodak GM 1mg/500mg/0.2mg Tablet SR

Managing Type 2 Diabetes

Major Benefits of Vodak GM 1mg/500mg/0.2mg Tablet SR:

Administer this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment schedule. The tablet should be swallowed whole; avoid chewing, crushing, or fracturing it. Consume Vodak GM 1mg/500mg/0.2mg Tablet SR on an empty stomach.

Common Side effects of Vodak GM 1mg/500mg/0.2mg Tablet SR:

  • Nausea
  • Diarrhea
  • Abdominal pain
  • Hypoglycemia (low blood glucose level)
  • Loss of appetite

How to use Vodak GM 1mg/500mg/0.2mg Tablet SR:

Administer this medication precisely as prescribed by your physician, adhering to the specified dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Vodak GM 1mg/500mg/0.2mg Extended-Release tablets should be taken on an empty stomach.

How Vodak GM 1mg/500mg/0.2mg Tablet SR works:

Each Vodak GM SR tablet (1mg/500mg/0.2mg) combines three distinct antidiabetic agents.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent alcohol use with Vodak GM 1mg/500mg/0.2mg SR tablets is contraindicated.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Vodak GM 1mg/500mg/0.2mg SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential benefits against any risks before prescribing this medication. Seek medical advice before using this drug.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The extended-release combination tablet, Vodak GM (1mg/500mg/0.2mg), is likely not safe for breastfeeding mothers. Available evidence from human studies indicates potential transfer of the medication into breast milk, posing a risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyUNSAFE

Employing Vodak GM 1mg/500mg/0.2mg Tablet SR carries a high likelihood of risk for individuals with impaired renal function and is best avoided. Medical advice is recommended. Furthermore, this medication is unsuitable for patients exhibiting severely compromised kidney function.

LiverLiverCAUTION

Patients with liver impairment should use Vodak GM 1mg/500mg/0.2mg SR tablets cautiously, potentially requiring dosage modification. Consult a physician. A low initial dose is generally recommended for individuals with mild to moderate hepatic dysfunction; however, the medication is contraindicated in those with severe liver disease.

What if you forget to take Vodak GM 1mg/500mg/0.2mg Tablet SR :

Should you forget to take a Vodak GM 1mg/500mg/0.2mg SR Tablet, administer it immediately upon remembering. Nevertheless, if your next scheduled dose is imminent, omit the missed tablet and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Vodak GM 1mg/500mg/0.2mg Tablet SR

LabelValue
Addictive None.
Treatment Category Medication for diabetes

FAQs on Vodak GM 1mg/500mg/0.2mg Tablet SR

Vodak GM 1mg/500mg/0.2mg Extended-Release tablets contain glimepiride, metformin, and voglibose. This triple-drug therapy manages type 2 diabetes mellitus in adults, enhancing glycemic control when coupled with a healthy diet and physical activity. Glimepiride stimulates pancreatic insulin secretion, thereby reducing blood glucose. Metformin decreases hepatic glucose production and increases insulin responsiveness. Voglibose, an alpha-glucosidase inhibitor, reduces post-meal blood sugar levels. This formulation is unsuitable for type 1 diabetes.
Patients taking Vodak GM 1mg/500mg/0.2mg Tablet SR may experience common adverse reactions including low blood sugar, nausea, diarrhea, changes in taste perception, gas, abdominal pain, headache, skin eruptions, and respiratory illness.
Patients with hypersensitivity to any constituent of Vodak GM 1mg/500mg/0.2mg Tablet SR should not take this medication. Its administration is contraindicated in individuals with moderate to severe renal impairment, and those experiencing inflammatory bowel disease, colonic ulcers, or underlying metabolic acidosis, such as diabetic ketoacidosis.
Combining Vodak GM 1mg/500mg/0.2mg SR tablets and alcohol is unsafe. This combination risks dangerously low blood sugar (hypoglycemia) and heightened lactic acidosis probability.
Indeed, Vodak GM 1mg/500mg/0.2mg SR Tablets can induce hypoglycemia. Low blood sugar symptoms may present as nausea, headache, irritability, hunger pangs, sweating, lightheadedness, tachycardia, and feelings of anxiety or tremor. The risk increases with skipped or delayed meals, alcohol consumption, excessive physical activity, or concomitant use of other antidiabetic medications. Consequently, consistent blood glucose monitoring is crucial. Carrying glucose tablets, honey, or fruit juice is recommended.
Retain this medication within its original, sealed packaging. Follow the storage guidelines provided on the packaging or label. Discard any leftover medication. Ensure it remains inaccessible to children, pets, and others.
Vodak GM 1mg/500mg/0.2mg ...
85
MRP 103
17% off